Vaccines for otitis media: Proposals for overcoming obstacles to progress

Vaccine

Volumn 23, Issue 21, 2005, Pages 2696-2702

  Murphy, Timothy F ^a,b,g   Bakaletz, Lauren O ^c   Kyd, Jennelle M ^d   Watson, Bracie ^e   Klein, David L ^f  

^a UNIVERSITY AT BUFFALO   (United States)

^b W NY Vet Affairs Healthcare System   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF CANBERRA   (Australia)

^e NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

^f NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^g VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

Author keywords

Immunization; Otitis media; Vaccine

Indexed keywords

ANTIGEN; BACTERIAL VACCINE; HAEMOPHILUS INFLUENZAE VACCINE; PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE; VIRUS VACCINE;

DRUG EFFICACY; ECONOMIC ASPECT; HUMAN; IMMUNIZATION; MORBIDITY; NONHUMAN; OTITIS MEDIA; PARAINFLUENZA VIRUS; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; REVIEW; VACCINATION; VIRUS INFECTION;

EID: 15044352891     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.12.014     Document Type: Article

References (67)

1. M.M. Rovers, A.G. Schilder, G.A. Zielhuis, and R.M. Rosenfeld Otitis media Lancet 363 9407 2004 465 473
2. Teele DW, Klein JO, Rosner B. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis 1989;160:83-94.
3. S.L. Block, C.J. Harrison, J. Hedrick, R. Tyler, A. Smith, and R. Hedrick Restricted use of antibiotic prophylaxis for recurrent acute otitis media in the era of penicillin non-susceptible Streptococcus pneumoniae Int J Pediatr Otorhinolaryngol 61 1 2001 47 60
4. H. Faden The microbiologic and immunologic basis for recurrent otitis media in children Eur J Pediatr 160 7 2001 407 413
5. D.W. Teele, J.O. Klein, C. Chase, P. Menyuk, B.A. Rosner, and R. Cohen Otitis media in infancy and intellectual ability, school achievement, speech, and language at age 7 years J Infect Dis 162 1990 685 694
6. J.O. Klein Otitis media Clin Infect Dis 19 1994 823 833
7. W.P. Hausdorff, G. Yothers, and R. Dagan Multinational study of pneumococcal serotypes causing acute otitis media in children Pediatr Infect Dis J 21 11 2002 1008 1016
8. K.J. Kvaerner, P. Nafstad, J.A. Hagen, I.W. Mair, and J.J. Jaakkola Recurrent acute otitis media: the significance of age at onset Acta Otolaryngol 117 4 1997 578 584
9. P. Homoe, R.B. Christensen, and P. Bretlau Acute otitis media and age at onset among children in Greenland Acta Otolaryngol 119 1 1999 65 71
10. S.L. Block, J. Hedrick, C.J. Harrison, R. Tyler, A. Smith, and R. Findlay Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media Pediatr Infect Dis J 23 9 2004 829 833
11. T. Heikkinen, and T. Chonmaitree Importance of respiratory viruses in acute otitis media Clin Microbiol Rev 16 2 2003 230 241
12. C.A. Buchman, and G.M. Brinson Viral otitis media Curr Allergy Asthma Rep 3 4 2003 335 340
13. T. Chonmaitree Viral and bacterial interaction in acute otitis media Pediatr Infect Dis J 19 5 Suppl. 2000 S24 S30
14. A. Pitkaranta, A. Virolainen, J. Jero, E. Arruda, and F.G. Hayden Detection of rhinovirus, respiratory syncytial virus, and coronavirus infections in acute otitis media by reverse transcriptase polymerase chain reaction Pediatrics 102 2 Pt 1 1998 291 295
15. J. Nokso-Koivisto, R. Raty, S. Blomqvist, M. Kleemola, R. Syrjanen, and A. Pitkaranta Presence of specific viruses in the middle ear fluids and respiratory secretions of young children with acute otitis media J Med Virol 72 2 2004 241 248
16. T. Heikkinen, M. Thint, and T. Chonmaitree Prevalence of various respiratory viruses in the middle ear during acute otitis media N Engl J Med 340 4 1999 260 264
17. T. Heikkinen, O. Ruuskanen, M. Waris, T. Ziegler, M. Arola, and P. Halonen Influenza vaccination in the prevention of acute otitis media in children Am J Dis Child 145 1991 445 448
18. D.A. Clements, L. Langdon, C. Bland, and E. Walter Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care Arch Pediatr Adolesc Med 149 10 1995 1113 1117
19. R.B. Belshe, P.M. Mendelman, J. Treanor, J. King, W.C. Gruber, and P. Piedra The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children N Engl J Med 338 20 1998 1405 1412
20. P. Marchisio, R. Cavagna, B. Maspes, S. Gironi, S. Esposito, and L. Lambertini Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children Clin Infect Dis 35 2 2002 168 174
21. A.W. Cripps, J.M. Kyd, and A.R. Foxwell Vaccines and mucosal immunisation Vaccine 19 17-19 2001 2513 2515
22. A.R. Foxwell, J.M. Kyd, and A.W. Cripps Mucosal immunization against respiratory bacterial pathogens Expert Rev Vaccines 2 4 2003 551 560
23. P.L. Ogra, H. Faden, and R.C. Welliver Vaccination strategies for mucosal immune responses Clin Microbiol Rev 14 2 2001 430 445
24. R.M. Jacobson, and G.A. Poland The pneumococcal conjugate vaccine Minerva Pediatr 54 4 2002 295 303
25. S.B. Black, H.R. Shinefield, J. Hansen, L. Elvin, D. Laufer, and F. Malinoski Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine Pediatr Infect Dis J 20 12 2001 1105 1107
26. S.L. Kaplan, E.O. Mason Jr, E.R. Wald, G.E. Schutze, J.S. Bradley, and T.Q. Tan Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine Pediatrics 113 3 Pt 1 2004 443 449
27. J. Eskola, T. Kilpi, A. Palmu, J. Jokinen, J. Haapakoski, and E. Herva Efficacy of a pneumococcal conjugate vaccine against acute otitis media N Engl J Med 344 6 2001 403 409
28. B. Fireman, S.B. Black, H.R. Shinefield, J. Lee, E. Lewis, and P. Ray Impact of the pneumococcal conjugate vaccine on otitis media Pediatr Infect Dis J 22 1 2003 10 16
29. C.J. Harrison Changes in treatment strategies for acute otitis media after full implementation of the pneumococcal seven valent conjugate vaccine Pediatr Infect Dis J 22 8 Suppl. 2003 S120 S130
30. S.M. Weber, and K.M. Grundfast Modern management of acute otitis media Pediatr Clin North Am 50 2 2003 399 411
31. D.E. Briles, S.K. Hollingshead, G.S. Nabors, J.C. Paton, and A. Brooks-Walter The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae Vaccine 19 Suppl. 1 2000 S87 S95
32. D. Bogaert, P.W. Hermans, P.V. Adrian, H.C. Rumke, and R. de Groot Pneumococcal vaccines: an update on current strategies Vaccine 22 17-18 2004 2209 2220
33. P.A. Shurin, S.I. Pelton, I.B. Tazer, and D.L. Kasper Bactericidal antibody and susceptibility to otitis media caused by nontypeable strains of Haemophilus influenzae J Pediatr 97 1980 364 369
34. H. Faden, J. Bernstein, L. Brodsky, J. Stanievich, D. Krystofik, and C. Shuff Otitis media in children. I. The systemic immune response to nontypeable Haemophilus influenzae J Infect Dis 160 1989 999 1004
35. C.M. Alper, A. Andalibi, L.O. Bakaletz, C. Buchman, P. Caye-Thomasen, and S.O. Hellstrom Recent advances in otitis media. 4. Anatomy, cell biology, pathology, and animal models Ann Otol Rhinol Laryngol Suppl 188 2002 36 51
36. L.O. Bakaletz, B.-J. Kennedy, L.A. Novotny, G. Duquesne, J. Cohen, and Y. Lobet Protection against development of otitis media induced by nontypeable Haemophilus influenzae by both active and passive immunization in a chinchilla model of virus-bacterium superinfection Infect Immun 67 1999 2746 2762
37. S.J. Barenkamp Immunization with high-molecular-weight adhesion proteins of nontypeable Haemophilus influenzae modifies experimental otitis media in chinchillas Infect Immun 64 1996 1246 1251
38. J. Sun, J. Chen, Z. Cheng, J.B. Robbins, J.F. Battey, and X.X. Gu Biological activities of antibodies elicited by lipooligosaccharide based-conjugate vaccines of nontypeable Haemophilus influenzae in an otitis media model Vaccine 18 13 2000 1264 1272
39. J.M. Kyd, and A.W. Cripps Potential of a novel protein, OMP26, from nontypeable Haemophilus influenzae to enhance pulmonary clearance in a rat model Infect Immun 66 1998 2272 2278
40. Y. Kurono, H. Shigemi, S. Kodama, and G. Mogi Effects of oral and systemic immunization on nasopharyngeal clearance of nontypeable Haemophilus influenzae in BALB/c mice Laryngoscope 106 1996 614 618
41. Y. Kurono, K. Skimamura, and G. Mogi Inhibition of nasopharyngeal colonization of Haemophilus influenzae by oral immunization Ann Otol Rhinol Laryngol 101 1992 11 15
42. D.J. Morton, L.O. Bakaletz, J.A. Jurcisek, T.M. Van Wagoner, T.W. Seale, and P.W. Whitby Reduced severity of middle ear infection caused by nontypeable Haemophilus influenzae lacking the hemoglobin/hemoglobin-haptoglobin binding proteins (Hgp) in a chinchilla model of otitis media Microb Pathog 36 1 2004 25 33
43. J.M. Kyd, A.W. Cripps, L.A. Novotny, and L.O. Bakaletz Efficacy of the 26-kilodalton outer membrane protein and two P5 fimbrin-derived immunogens to induce clearance of nontypeable Haemophilus influenzae from the rat middle ear and lungs as well as from the chinchilla middle ear and nasopharynx Infect Immun 71 8 2003 4691 4699
44. A. Sabirov, S. Kodama, T. Hirano, M. Suzuki, and G. Mogi Intranasal immunization enhances clearance of nontypeable Haemophilus influenzae and reduces stimulation of tumor necrosis factor (production in the murine model of otitis media Infect Immun 69 5 2001 2964 2971
45. T.F. Murphy Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response Microbiol Rev 60 1996 267 279
46. I. Maciver, M. Unhanand, G.H. McCracken Jr, and E.J. Hansen Effect of immunization on pulmonary clearance of Moraxella catarrhalis in an animal model J Infect Dis 168 1993 469 472
47. T.F. Murphy, J.M. Kyd, A. John, C. Kirkham, and A.W. Cripps Enhancement of pulmonary clearance of Moraxella (Branhamella) catarrhalis following immunization with outer membrane protein CD in a mouse model J Infect Dis 178 1998 1667 1675
48. J. Kyd, A. John, A. Cripps, and T.F. Murphy Investigation of mucosal immunisation in pulmonary clearance of Moraxella (Branhamella) catarrhalis Vaccine 18 2000 398 406
49. D. Chen, J.C. McMichael, K.R. van der Meid, D. Hahn, T. Mininni, and J. Cowell Evaluation of purified UspA from Moraxella catarrhalis as a vaccine in a murine model after active immunization Infect Immun 64 1996 1900 1905
50. L.O. Bakaletz, D.M. Murwin, and J.M. Billy Adenovirus serotype 1 does not act synergistically with Moraxella (Branhamella) catarrhalis to induce otitis media in the chinchilla Infect Immun 63 1995 4188 4190
51. M.L. Barbour Conjugate vaccines and the carriage of Haemophilus influenzae type b Emerg Infect Dis 2 3 1996 176 182
52. M.L. Barbour, R.T. Mayon-White, C. Coles, D.W. Crook, and E.R. Moxon The impact of conjugate vaccine on carriage of Haemophilus influenzae type b J Infect Dis 171 1 1995 93 98
53. J. Fernandez, O.S. Levine, J. Sanchez, S. Balter, L. LaClaire, and J. Feris Prevention of Haemophilus influenzae type b colonization by vaccination: correlation with serum anti-capsular IgG concentration J Infect Dis 182 5 2000 1553 1556
54. K.L. O'Brien, and R. Dagan The potential indirect effect of conjugate pneumococcal vaccines Vaccine 21 17-18 2003 1815 1825
55. R. Dagan, N. Givon-Lavi, O. Zamir, and D. Fraser Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers Pediatr Infect Dis J 22 6 2003 532 540
56. R. Dagan, N. Givon-Lavi, O. Zamir, M. Sikuler-Cohen, L. Guy, and L. Janco Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers J Infect Dis 185 7 2002 927 936
57. N. Givon-Lavi, D. Fraser, and R. Dagan Vaccination of day-care center attendees reduces carriage of Streptococcus pneumoniae among their younger siblings Pediatr Infect Dis J 22 6 2003 524 532
58. X.X. Gu, S.F. Rudy, C. Chu, L. McCullagh, H.N. Kim, and J. Chen Phase I study of a lipooligosaccharide-based conjugate vaccine against nontypeable Haemophilus influenzae Vaccine 21 17-18 2003 2107 2114
59. D.L. Klein A phase II multicenter evaluation of several candidate pertussis vaccines in infants Dev Biol Stand 73 1991 305 309
60. D.L. Klein Multicenter acellular pertussis vaccine trial: a National Institutes of Health perspective Pediatrics 96 3 Pt 2 1995 547 548
61. L.-E. Stenfors, and S. Raisanen Quantitative analysis of the bacterial findings in otitis media J Laryngol Otol 104 1990 749 757
62. V.N. Gan, H. Kusmiesz, S. Shelton, and J.D. Nelson Comparative evaluation of loracarbef and amoxicillin-clavulanate for acute otitis media Antimicrob Agents Chemother 35 1991 967 971
63. H. Faden, J. Bernstein, J. Stanievich, L. Brodsky, and P.L. Ogra Effect of prior antibiotic treatment on middle ear disease in children Ann Otol Rhinol Laryngol 101 1992 87 91
64. M.A. DelBeccaro, P.M. Mendelman, A.F. Inglis, M.A. Richardson, N.O. Duncan, and C.R. Clausen Bacteriology of acute otitis media: a new perspective J Pediatr 120 1992 81 84
65. T. Chonmaitree, M.J. Owen, J.A. Patel, D. Hedgpeth, D. Horlick, and V.M. Howie Effect of viral respiratory tract infection on outcome of acute otitis media J Pediatr 120 1992 856 862
66. M.M. Aspin, A. Hoberman, J. McCarty, S.E. McLinn, S. Aronoff, and D.J. Lang Comparative study of the safety and efficacy of clarithromycin and amoxicillin-clavulanate in the treatment of acute otitis media in children J Pediatr 125 1994 135 141
67. T. Kilpi, E. Herva, T. Kaijalainen, R. Syrjanen, and A.K. Takala Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life Pediatr Infect Dis J 20 7 2001 654 662